Particle.news

Download on the App Store

Delhi High Court Declines Stay in Gambhir Foundation Covid Drug Case

The judge set an August 29 hearing on a plea to quash a Drugs and Cosmetics Act complaint tied to a 2021 medical camp.

Image
Image

Overview

  • The court refused to restore an interim stay on proceedings against the Gautam Gambhir Foundation and named trustees over alleged unlicensed distribution of Covid drugs.
  • Justice Neena Bansal Krishna rebuked the defence for “name-dropping,” calling references to public credentials and relief work irrelevant to the legal issues.
  • The April 9 order vacating the earlier 2021 stay remains in effect, with the High Court to consider the quashing petition on August 29.
  • The underlying complaint by Delhi’s Drugs Control Department cites alleged stocking and distribution without licence, with provisions reported to include Sections 18(c) and 27(b)(ii).
  • The accused include Gautam Gambhir, his wife Natasha, his mother Seema, and GGF CEO Aparajita Singh, and the trial court has its next date on September 8.